Endologix LLC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$6.5Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
4,901clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Nicolas Mouawad | West Branch, MI | Vascular Surgery | $251,699.27 |
| Sonya Noor | Buffalo, NY | Vascular Surgery | $165,707.54 |
| John Lane | San Diego, CA | Vascular Surgery | $164,327.09 |
| Venkatesh Ramaiah | Scottsdale, AZ | Vascular Surgery | $147,588.37 |
| Roberto Cervera | Lake Havasu City, AZ | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $143,944.57 |
| Juan Ayerdi | Columbus, GA | Vascular Surgery | $116,250.40 |
| Mark Conrad | Methuen, MA | Surgery | $115,493.68 |
| Baljeet Uppal | Sun City, AZ | Vascular Surgery | $109,209.20 |
| John Park | Omaha, NE | Vascular Surgery | $98,785.87 |
| Anthony Feghali | Syracuse, NY | Vascular Surgery | $97,824.81 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.